Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1168P is a pseudogene locus annotated as "RNA, U6 small nuclear 1168, pseudogene" in the human genome[4][5]. It is one of many non-coding, nonfunctional copies of the U6 small nuclear RNA (snRNA) gene, which itself is a key RNA component of the spliceosome complex involved in removal of introns from precursor mRNA in eukaryotes[3]. The U6 pseudogenes, including RNU6-1168P, usually do not produce stable or functional RNAs, and do not encode proteins or serve as biological regulators. Their biological significance, if any, is not established. Such pseudogenes are not considered therapeutic targets nor are they linked to any known pharmacological activity or clinical interventions[5][7]. The parent functional gene, U6 snRNA (not this pseudogene), is essential for RNA splicing[1][3][9]. U6 pseudogenes are common in the human genome but their roles—unlike those of certain "processed pseudogenes" for protein-coding RNAs—are mostly unknown and not druggable[2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1168, pseudogene (RNU6-1168P).